These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4657117)

  • 21. [Current antibacterial therapy in high-risk subjects].
    Antimi M
    Recenti Prog Med; 1982 Feb; 72(2):133-8. PubMed ID: 7100616
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical implications of the mechanism of action of antimicrobial agents.
    Swenson RM; Sanford JP
    Adv Intern Med; 1970; 16():373-99. PubMed ID: 4916364
    [No Abstract]   [Full Text] [Related]  

  • 23. [Can one use probabilistic protocols for antibiotic therapy in intensive care units?].
    Bourdain N; Lepape A; Galzot F; Lamy B; Haessler D; Chomarat M; Grozel JM; Banssillon V
    Pathol Biol (Paris); 1999 May; 47(5):584-8. PubMed ID: 10418047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy of bacterial corneal diseases].
    Heimann K
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1972; 71():260-5. PubMed ID: 4679322
    [No Abstract]   [Full Text] [Related]  

  • 25. New antimicrobial agents for use in the intensive care unit.
    Ritchie DJ; Alexander BT; Finnegan PM
    Infect Dis Clin North Am; 2009 Sep; 23(3):665-81. PubMed ID: 19665089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bibliography. Current world literature. Antimicrobial agents: bacterial/fungal.
    Curr Opin Infect Dis; 2002 Dec; 15(6):615-21. PubMed ID: 12825593
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antimicrobial therapy through fodder].
    Nicolet J
    Schweiz Arch Tierheilkd; 1983 Apr; 125(4):185-92. PubMed ID: 6867664
    [No Abstract]   [Full Text] [Related]  

  • 28. Europe, Austria and the battle against antimicrobial resistance.
    Hrabcik H
    Wien Klin Wochenschr; 2008; 120(9-10):253-4, 254-5. PubMed ID: 18545947
    [No Abstract]   [Full Text] [Related]  

  • 29. Appropriate antibiotic use: reducing the emergence and dissemination of resistance.
    Low DE
    Int J Clin Pract Suppl; 2000 Dec; (115):106-10. PubMed ID: 11219292
    [No Abstract]   [Full Text] [Related]  

  • 30. The newer fluoroquinolones.
    O'Donnell JA; Gelone SP
    Infect Dis Clin North Am; 2004 Sep; 18(3):691-716, x. PubMed ID: 15308282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empirical antimicrobial therapy for traveler's diarrhea.
    Adachi JA; Ostrosky-Zeichner L; DuPont HL; Ericsson CD
    Clin Infect Dis; 2000 Oct; 31(4):1079-83. PubMed ID: 11049792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibiotics, that only "disarm" the pathogen. Complex action mechanisms of modern antimicrobial substances].
    Knauer RH
    Fortschr Med; 1999 Jan; 117(3):17. PubMed ID: 10087630
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic strategies involving antimicrobial treatment of the gastrointestinal tract in large animals.
    Whitlock RH
    J Am Vet Med Assoc; 1984 Nov; 185(10):1210-3. PubMed ID: 6392259
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of quorum-sensing blockers as therapeutic agents for the control of biofilm-associated infections.
    Rice SA; McDougald D; Kumar N; Kjelleberg S
    Curr Opin Investig Drugs; 2005 Feb; 6(2):178-84. PubMed ID: 15751741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of antimicrobial agents in the course of renal insufficiency].
    Novi C
    Clin Ter; 1972 Aug; 62(3):273-86. PubMed ID: 5081154
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Olapade-Olaopa EO; Adebayo SA
    J Urol; 2006 Jun; 175(6):2365-6; author reply 2366. PubMed ID: 16697876
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of central nervous system infections in small animals.
    Fenner WR
    J Am Vet Med Assoc; 1984 Nov; 185(10):1176-80. PubMed ID: 6392251
    [No Abstract]   [Full Text] [Related]  

  • 38. [Initial empiric treatment of pneumonia and the new antibiotics].
    Parent M
    Union Med Can; 1994 Jan; 123(1):14-8. PubMed ID: 8109061
    [No Abstract]   [Full Text] [Related]  

  • 39. Bacterial virulence and the development of novel antimicrobial approaches.
    Sun H
    Curr Drug Targets; 2012 Mar; 13(3):294-6. PubMed ID: 22206252
    [No Abstract]   [Full Text] [Related]  

  • 40. [Sensitivity of some bacterial species isolated from urinary infections to antimicrobial agents].
    Meitert E; Sima F; Savulian C; Chersulick E; Petrescu AM
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(2):145-54. PubMed ID: 6463514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.